Drawing for PDSSCS

USPTO serial 79456900

PDSSCS

Reviewed by CopyMark Law Group

Status 640Office Action
Filing date
Status date
Registration date
—
Examiner
TOOLEY, DAVID E
Law office
TMO LAW OFFICE 125

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Status 640: Status 640 means the examining attorney has prepared a non-final Office Action but it has not been mailed or e-mailed yet. The action should appear in TSDR soon, and a response deadline will start once it is issued.

Need help with PDSSCS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Medicines for the treatment of cardiovascular and cerebrovascular diseases; biological preparations for the treatment of neurodegeneration; pharmaceutical preparations for the treatment of neurodegeneration; pharmaceutical preparations for skin care; cultures of microorganisms for medical or veterinary use; pharmaceutical preparations for the treatment of Amyotrophic lateral sclerosis; biological tissue cultures for medical purposes; injectable dermal fillers; stem cells for medical purposes.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 22, 2026RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 21, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 16, 2026DOCKASSIGNED TO EXAMINER—
Sep 1, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 1, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 31, 2026LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Aug 27, 2026REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance